Pharmaceuticals Stocks

Vertex Pharmaceuticals Inc Valuation – February 2019 $VRTX

Vertex Pharmaceuticals Incorporated does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Pharmaceuticals Stocks

Ligand Pharmaceuticals Inc Valuation – September 2018 $LGND

Ligand Pharmaceuticals Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Back To Top